CN100998869A
(zh)
|
1993-07-19 |
2007-07-18 |
血管技术药物公司 |
抗血管生长组合物及使用方法
|
US5994341A
(en)
*
|
1993-07-19 |
1999-11-30 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic Compositions and methods for the treatment of arthritis
|
US5443505A
(en)
*
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
US5620013A
(en)
*
|
1994-10-21 |
1997-04-15 |
American Cyanamid Company |
Method for destroying residual lens epithelial cells
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
US5904144A
(en)
*
|
1996-03-22 |
1999-05-18 |
Cytotherapeutics, Inc. |
Method for treating ophthalmic diseases
|
US6063370A
(en)
*
|
1996-04-05 |
2000-05-16 |
The Board Of Trustees Of The University Of Illinois |
Macromolecular complexes for drug delivery
|
US5935599A
(en)
*
|
1996-10-28 |
1999-08-10 |
The Board Of Trustees Of The University Of Illinois |
Polymer-associated liposomes for drug delivery and method of manufacturing the same
|
JP2001513369A
(ja)
*
|
1997-08-11 |
2001-09-04 |
アラーガン・セイルズ・インコーポレイテッド |
改善された生物適合性を有する無菌の生物侵食性の移植デバイスおよび方法
|
US6007578A
(en)
|
1997-10-08 |
1999-12-28 |
Ras Holding Corp |
Scleral prosthesis for treatment of presbyopia and other eye disorders
|
US6991650B2
(en)
|
1997-10-08 |
2006-01-31 |
Refocus Ocular, Inc. |
Scleral expansion device having duck bill
|
WO1999055396A1
(en)
|
1998-04-27 |
1999-11-04 |
Surmodics, Inc. |
Bioactive agent release coating
|
WO2000000106A1
(en)
*
|
1998-06-29 |
2000-01-06 |
Rozakis George W |
Antioxidant intraocular lens
|
US6024719A
(en)
*
|
1998-07-06 |
2000-02-15 |
Morris; Robert E |
Method and apparatus for performing surgery inside the human retina using fluidic internal limiting membrane (ILM) seperation (FILMS)
|
US6378526B1
(en)
|
1998-08-03 |
2002-04-30 |
Insite Vision, Incorporated |
Methods of ophthalmic administration
|
US6309374B1
(en)
|
1998-08-03 |
2001-10-30 |
Insite Vision Incorporated |
Injection apparatus and method of using same
|
FR2787991B1
(fr)
*
|
1998-12-31 |
2001-05-25 |
Medicale De Prec S M P Sa Soc |
Dispositif pour traiter la presbytie ou autre affection oculaire
|
EP1154691A4
(de)
*
|
1999-01-05 |
2004-07-07 |
Massachusetts Eye & Ear Infirm |
Gezielte transsklerale gesteuerte wirkstoffabgabe an die retina und choroidae
|
US6113638A
(en)
*
|
1999-02-26 |
2000-09-05 |
Williams; Lytton A. |
Method and apparatus for intervertebral implant anchorage
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
MXPA01010832A
(es)
|
1999-04-26 |
2003-06-30 |
Gmp Vision Solutions Inc |
Dispositivo de derivacion y metodo para el tratamiento del glaucoma.
|
US6699210B2
(en)
*
|
1999-04-27 |
2004-03-02 |
The Arizona Board Of Regents |
Glaucoma shunt and a method of making and surgically implanting the same
|
EP1754453B1
(de)
|
1999-06-07 |
2010-09-29 |
Refocus Ocular, Inc. |
Skleraprothese zur Behandlung der Weitsichtigkeit und anderer Augenkrankheiten
|
US7008396B1
(en)
|
1999-09-03 |
2006-03-07 |
Restorvision, Inc. |
Ophthalmic device and method of manufacture and use
|
DE19947711B4
(de)
*
|
1999-10-04 |
2004-02-12 |
Schrage, Norbert, Priv. Doz. Dr.med. |
Implantat zum Eisatz in der Glaukomtherapie
|
ES2240180T3
(es)
|
1999-10-21 |
2005-10-16 |
Alcon Inc. |
Administracion sub-tenon de medicamentos.
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
US6416777B1
(en)
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
DE60040876D1
(de)
|
1999-10-21 |
2009-01-02 |
Alcon Inc |
Medikamentenzuführeinrichtung
|
US6331313B1
(en)
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
US6852688B2
(en)
|
2000-03-10 |
2005-02-08 |
University Of Florida |
Compositions for treating diabetic retinopathy and methods of using same
|
US20050277864A1
(en)
*
|
2000-04-14 |
2005-12-15 |
David Haffner |
Injectable gel implant for glaucoma treatment
|
US20040111050A1
(en)
*
|
2000-04-14 |
2004-06-10 |
Gregory Smedley |
Implantable ocular pump to reduce intraocular pressure
|
US20050049578A1
(en)
*
|
2000-04-14 |
2005-03-03 |
Hosheng Tu |
Implantable ocular pump to reduce intraocular pressure
|
US7708711B2
(en)
|
2000-04-14 |
2010-05-04 |
Glaukos Corporation |
Ocular implant with therapeutic agents and methods thereof
|
US20020143284A1
(en)
*
|
2001-04-03 |
2002-10-03 |
Hosheng Tu |
Drug-releasing trabecular implant for glaucoma treatment
|
US7867186B2
(en)
|
2002-04-08 |
2011-01-11 |
Glaukos Corporation |
Devices and methods for treatment of ocular disorders
|
US6638239B1
(en)
|
2000-04-14 |
2003-10-28 |
Glaukos Corporation |
Apparatus and method for treating glaucoma
|
US6375972B1
(en)
*
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
US6417237B1
(en)
|
2000-06-08 |
2002-07-09 |
The Board Of Trustees Of The University Of Illinois |
Macromolecular drug complexes and compositions containing the same
|
US6692759B1
(en)
*
|
2000-06-28 |
2004-02-17 |
The Regents Of The University Of California |
Methods for preparing and using implantable substance delivery devices
|
US6726918B1
(en)
*
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
EP3167872B1
(de)
|
2000-07-05 |
2020-10-14 |
Allergan, Inc. |
Verfahren zur behandlung von entzündungsbedingten zuständen der augen
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
DE60135352D1
(de)
*
|
2000-08-30 |
2008-09-25 |
Univ Johns Hopkins |
Vorrichtung zur intraokularen wirkstoffverabreichung
|
PE20020578A1
(es)
|
2000-10-10 |
2002-08-14 |
Upjohn Co |
Una composicion de antibiotico topico para el tratamiento de infecciones oculares
|
AU2002248284A1
(en)
*
|
2000-11-01 |
2002-08-06 |
Allergan, Inc. |
Compositions for treatment of ocular neovascularization
|
US20030082183A1
(en)
*
|
2000-11-01 |
2003-05-01 |
Wheeler Larry A. |
Methods and compositions for treatment of ocular neovascularization and neural injury
|
US6534693B2
(en)
*
|
2000-11-06 |
2003-03-18 |
Afmedica, Inc. |
Surgically implanted devices having reduced scar tissue formation
|
CA2429998C
(en)
|
2000-11-29 |
2012-01-17 |
Oculex Pharmaceuticals, Inc. |
Intraocular implants for preventing transplant rejection in the eye
|
JP4657577B2
(ja)
|
2001-01-09 |
2011-03-23 |
マイクロチップス・インコーポレーテッド |
眼への適用および他への適用のための可撓性マイクロチップデバイス
|
US6713081B2
(en)
*
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
US7488303B1
(en)
*
|
2002-09-21 |
2009-02-10 |
Glaukos Corporation |
Ocular implant with anchor and multiple openings
|
EP1977724A1
(de)
|
2001-04-07 |
2008-10-08 |
Glaukos Corporation |
System zur Behandlung von Augenstörungen
|
US6981958B1
(en)
*
|
2001-05-02 |
2006-01-03 |
Glaukos Corporation |
Implant with pressure sensor for glaucoma treatment
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
US7795218B2
(en)
|
2001-04-12 |
2010-09-14 |
Bioaxone Therapeutique Inc. |
ADP-ribosyl transferase fusion variant proteins
|
US20040022853A1
(en)
*
|
2001-04-26 |
2004-02-05 |
Control Delivery Systems, Inc. |
Polymer-based, sustained release drug delivery system
|
US7678065B2
(en)
|
2001-05-02 |
2010-03-16 |
Glaukos Corporation |
Implant with intraocular pressure sensor for glaucoma treatment
|
WO2002089767A1
(en)
|
2001-05-03 |
2002-11-14 |
Massachusetts Eye And Ear Infirmary |
Implantable drug delivery device and use thereof
|
US7094225B2
(en)
|
2001-05-03 |
2006-08-22 |
Glaukos Corporation |
Medical device and methods of use of glaucoma treatment
|
US20060241750A1
(en)
*
|
2001-05-22 |
2006-10-26 |
Ras Holding Corp |
Scleral expansion device having duck bill
|
ATE506929T1
(de)
|
2001-06-12 |
2011-05-15 |
Univ Johns Hopkins Med |
Reservoirvorrichtung für die intraokulare arzneimittelabgabe
|
US7592016B2
(en)
*
|
2001-06-28 |
2009-09-22 |
Regents Of The University Of California |
Methods for preparing and using implantable substance delivery devices
|
DE10133870A1
(de)
*
|
2001-07-12 |
2003-02-06 |
Chris P Lohmann |
Ophthalmisches Mittel, Verwendung von EGF zur Behandlung von Dry Eye-Syndrom und Insert zur Verabreichung von EGF am Auge
|
AU2002319606B2
(en)
*
|
2001-07-23 |
2006-09-14 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
PT1409065E
(pt)
|
2001-07-23 |
2007-03-30 |
Alcon Inc |
Dispositivo de administração de fármacos oftálmicos
|
US8267995B2
(en)
*
|
2001-08-03 |
2012-09-18 |
David Castillejos |
Method and intra sclera implant for treatment of glaucoma and presbyopia
|
US7331984B2
(en)
|
2001-08-28 |
2008-02-19 |
Glaukos Corporation |
Glaucoma stent for treating glaucoma and methods of use
|
BR0205990A
(pt)
*
|
2001-08-29 |
2004-01-13 |
Ricardo Azevedo Ponte Carvalho |
Um sistema implantável de liberação unidirecional de agentes terapêuticos para tecidos
|
GB0122318D0
(en)
*
|
2001-09-14 |
2001-11-07 |
Novartis Ag |
Organic compounds
|
IN2014DN10834A
(de)
*
|
2001-09-17 |
2015-09-04 |
Psivida Inc |
|
ES2282483T3
(es)
*
|
2001-10-30 |
2007-10-16 |
Eyeborn (Proprietary) Limited |
Implante orbital.
|
FR2833493B1
(fr)
*
|
2001-12-18 |
2005-09-23 |
Ioltechnologie Production |
Forme galenique solide et soluble pour l'administration occulaire de principes actifs et procede de fabrication d'un insert ophtalmique solide et soluble
|
US20030180294A1
(en)
*
|
2002-02-22 |
2003-09-25 |
Devries Gerald W. |
Methods of extending corneal graft survival
|
US7186232B1
(en)
|
2002-03-07 |
2007-03-06 |
Glaukoa Corporation |
Fluid infusion methods for glaucoma treatment
|
KR101127502B1
(ko)
*
|
2002-03-11 |
2012-03-23 |
알콘, 인코퍼레이티드 |
이식 가능한 약물 전달 시스템
|
US7951155B2
(en)
|
2002-03-15 |
2011-05-31 |
Glaukos Corporation |
Combined treatment for cataract and glaucoma treatment
|
US20040147870A1
(en)
*
|
2002-04-08 |
2004-07-29 |
Burns Thomas W. |
Glaucoma treatment kit
|
US9301875B2
(en)
|
2002-04-08 |
2016-04-05 |
Glaukos Corporation |
Ocular disorder treatment implants with multiple opening
|
US20040024345A1
(en)
*
|
2002-04-19 |
2004-02-05 |
Morteza Gharib |
Glaucoma implant with valveless flow bias
|
WO2003092665A2
(en)
*
|
2002-05-02 |
2003-11-13 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
BR0309844A
(pt)
*
|
2002-05-07 |
2005-02-15 |
Control Delivery Sys Inc |
Processos para formação de um dispositivo para a distribuição de droga
|
US7097850B2
(en)
|
2002-06-18 |
2006-08-29 |
Surmodics, Inc. |
Bioactive agent release coating and controlled humidity method
|
ATE346544T1
(de)
*
|
2002-07-09 |
2006-12-15 |
Anglo Europ College Of Chiropr |
Verfahren zur bilddarstellung der relativen bewegung von skelettsegmenten
|
DK1521573T3
(da)
*
|
2002-07-15 |
2008-03-25 |
Alcon Inc |
Ikke-polymere, lipofile, farmaceutiske implantatsammensætninger til intrakulær anvendelse
|
US20070184089A1
(en)
*
|
2002-07-15 |
2007-08-09 |
Alcon, Inc. |
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
|
US20070027537A1
(en)
*
|
2002-08-02 |
2007-02-01 |
David Castillejos |
Method and intra-sclera implant for treatment of glaucoma and presbyopia
|
US7699882B2
(en)
*
|
2002-09-17 |
2010-04-20 |
Iscience Interventional Corporation |
Apparatus and method for surgical bypass of aqueous humor
|
US7468065B2
(en)
|
2002-09-18 |
2008-12-23 |
Allergan, Inc. |
Apparatus for delivery of ocular implants
|
US20050203542A1
(en)
*
|
2002-09-18 |
2005-09-15 |
Allergan, Inc. |
Apparatus for delivery of ocular implants with reduced incidence of ocular adverse events
|
EP1539065B1
(de)
|
2002-09-18 |
2012-12-12 |
Allergan, Inc. |
Geräte zur zuführung von augenimplantaten
|
US6899717B2
(en)
*
|
2002-09-18 |
2005-05-31 |
Allergan, Inc. |
Methods and apparatus for delivery of ocular implants
|
WO2004036182A2
(en)
*
|
2002-10-17 |
2004-04-29 |
Control Delivery Systems, Inc. |
Methods for monitoring treatment of disease
|
US20040111144A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Lawin Laurie R. |
Barriers for polymeric coatings
|
PT1585743E
(pt)
*
|
2002-12-19 |
2007-07-12 |
Pfizer |
Compostos de 2- (1h-indazol-6-ilamin)-benzamida como inibidores de proteína-cinases úteis para o tratamento de doenças aftálmicas.
|
US20060166879A1
(en)
*
|
2002-12-20 |
2006-07-27 |
Chakshu Research Inc |
Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
|
NZ540885A
(en)
*
|
2002-12-20 |
2009-02-28 |
Chakshu Res Inc |
Ophthalmic formulation for the prevention and treatment of ocular conditions
|
US20060172972A1
(en)
*
|
2002-12-20 |
2006-08-03 |
Chakshu Research Inc |
Formulation and method for administration of ophthalmologically active agents
|
US20060177430A1
(en)
*
|
2002-12-20 |
2006-08-10 |
Chakshu Research Inc |
Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
|
US8185209B2
(en)
*
|
2003-01-03 |
2012-05-22 |
Board Of Trustees Operating Michigan State University |
Methods to extend vision to infrared wavelengths
|
US20050048099A1
(en)
*
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
US20040137059A1
(en)
|
2003-01-09 |
2004-07-15 |
Thierry Nivaggioli |
Biodegradable ocular implant
|
WO2004073551A2
(en)
*
|
2003-02-18 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Transscleral drug delivery device and related methods
|
US9216106B2
(en)
|
2003-04-09 |
2015-12-22 |
Directcontact Llc |
Device and method for the delivery of drugs for the treatment of posterior segment disease
|
ATE476960T1
(de)
|
2003-05-02 |
2010-08-15 |
Surmodics Inc |
System zur kontrollierten freisetzung eines bioaktiven wirkstoffs im hinteren bereich des auges
|
US8246974B2
(en)
|
2003-05-02 |
2012-08-21 |
Surmodics, Inc. |
Medical devices and methods for producing the same
|
US20040225250A1
(en)
|
2003-05-05 |
2004-11-11 |
Michael Yablonski |
Internal shunt and method for treating glaucoma
|
US7589107B2
(en)
|
2003-05-19 |
2009-09-15 |
Othera Holding, Inc. |
Amelioration of vitrectomy-induced cataracts
|
JP2007526019A
(ja)
*
|
2003-07-10 |
2007-09-13 |
アルコン,インコーポレイティド |
眼科用薬物送達デバイス
|
US20050009910A1
(en)
*
|
2003-07-10 |
2005-01-13 |
Allergan, Inc. |
Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
|
ES2391975T3
(es)
*
|
2003-07-25 |
2012-12-03 |
Genvec, Inc. |
Vacunas a base de vector adenovírico
|
CN102144961A
(zh)
|
2003-09-18 |
2011-08-10 |
参天制药株式会社 |
经巩膜递送
|
US20050101582A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
US20050250737A1
(en)
*
|
2003-11-12 |
2005-11-10 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
US20070224278A1
(en)
*
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
US20050098470A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Davis Michael J. |
Kit for administration of a drug
|
SI1696822T1
(sl)
*
|
2003-11-13 |
2010-07-30 |
Psivida Inc |
Injektibilen implantat z zadržanim sproščanjem, ki ima bioerodibilno matično jedro in bioerodibilno kožo
|
EP1687032B1
(de)
|
2003-11-14 |
2010-02-24 |
Genvec, Inc. |
Pharmazeutische verbindung zur behandlung von lokal fortgeschrittenem primär inoperablen pankreaskarzinom (lapc).
|
US7291125B2
(en)
|
2003-11-14 |
2007-11-06 |
Transcend Medical, Inc. |
Ocular pressure regulation
|
CA2546042A1
(en)
|
2003-11-20 |
2005-06-09 |
Othera Pharmaceuticals, Inc. |
Amelioration of macular degeneration and other ophthalmic diseases
|
US20080220049A1
(en)
*
|
2003-12-05 |
2008-09-11 |
Adnexus, A Bristol-Myers Squibb R&D Company |
Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
|
KR20060129246A
(ko)
|
2003-12-05 |
2006-12-15 |
컴파운드 쎄라퓨틱스, 인크. |
타입 2 혈관 내피 성장 인자 수용체의 억제제
|
US7211272B2
(en)
*
|
2003-12-22 |
2007-05-01 |
Bausch & Lomb Incorporated |
Drug delivery device
|
BRPI0506983A
(pt)
|
2004-01-20 |
2007-07-03 |
Allergan Inc |
composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico
|
US20050250788A1
(en)
*
|
2004-01-30 |
2005-11-10 |
Hosheng Tu |
Aqueous outflow enhancement with vasodilated aqueous cavity
|
CN1964748A
(zh)
|
2004-04-06 |
2007-05-16 |
苏莫迪克斯公司 |
用于生物活性剂的涂料组合物
|
AU2005243730B2
(en)
|
2004-04-12 |
2010-05-27 |
Genvec, Inc. |
Method of using adenoviral vectors to induce an immune response
|
US20050232972A1
(en)
|
2004-04-15 |
2005-10-20 |
Steven Odrich |
Drug delivery via punctal plug
|
US7691381B2
(en)
*
|
2004-04-15 |
2010-04-06 |
Allergan, Inc. |
Stabilized biodegradable neurotoxin implants
|
US9549895B2
(en)
*
|
2004-04-23 |
2017-01-24 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
MXPA06012460A
(es)
*
|
2004-04-29 |
2007-07-13 |
Iscience Surgical Corp |
Metodo y aparato para mejora quirurgica de drenaje de humor acuoso.
|
US20080058704A1
(en)
*
|
2004-04-29 |
2008-03-06 |
Michael Hee |
Apparatus and Method for Ocular Treatment
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
US20050244463A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
US20050244500A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intravitreal implants in conjuction with photodynamic therapy to improve vision
|
US20070212395A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Allergan, Inc. |
Ocular therapy using sirtuin-activating agents
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
US8673341B2
(en)
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
US20050244469A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
US20060182781A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Methods for treating ocular conditions with cyclic lipid contraining microparticles
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
US20060182783A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
WO2005110374A1
(en)
*
|
2004-04-30 |
2005-11-24 |
Allergan, Inc. |
Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
|
US20050244462A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
US8529927B2
(en)
*
|
2004-04-30 |
2013-09-10 |
Allergan, Inc. |
Alpha-2 agonist polymeric drug delivery systems
|
AU2011213904B2
(en)
*
|
2004-04-30 |
2014-06-05 |
Allergan, Inc. |
Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8425929B2
(en)
*
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
US8512738B2
(en)
|
2004-04-30 |
2013-08-20 |
Allergan, Inc. |
Biodegradable intravitreal tyrosine kinase implants
|
US7589057B2
(en)
|
2004-04-30 |
2009-09-15 |
Allergan, Inc. |
Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
|
US8685435B2
(en)
|
2004-04-30 |
2014-04-01 |
Allergan, Inc. |
Extended release biodegradable ocular implants
|
US20050244461A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
US20050244471A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
US8119154B2
(en)
*
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
US8980930B2
(en)
|
2004-06-25 |
2015-03-17 |
The Johns Hopkins University |
Angiogenesis inhibitors
|
DK1765454T3
(en)
|
2004-07-02 |
2016-05-02 |
Mati Therapeutics Inc |
Device for submission of treatment medium to eye
|
US20060110428A1
(en)
*
|
2004-07-02 |
2006-05-25 |
Eugene Dejuan |
Methods and devices for the treatment of ocular conditions
|
WO2006017347A2
(en)
*
|
2004-07-12 |
2006-02-16 |
Allergan, Inc. |
Opthalmic compositions and methods for treating ophthalmic conditions
|
US20090214588A1
(en)
|
2004-07-16 |
2009-08-27 |
Nabel Gary J |
Vaccines against aids comprising cmv/r-nucleic acid constructs
|
US7117870B2
(en)
*
|
2004-07-26 |
2006-10-10 |
Clarity Corporation |
Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
|
WO2006078320A2
(en)
|
2004-08-04 |
2006-07-27 |
Brookwood Pharmaceuticals, Inc. |
Methods for manufacturing delivery devices and devices thereof
|
US7722669B2
(en)
|
2004-08-13 |
2010-05-25 |
Richard Foulkes |
Method and insert for modifying eye color
|
US8246569B1
(en)
|
2004-08-17 |
2012-08-21 |
California Institute Of Technology |
Implantable intraocular pressure drain
|
US20060047250A1
(en)
*
|
2004-08-30 |
2006-03-02 |
Hickingbotham Dyson W |
Fluid delivery device
|
CA2589602A1
(en)
*
|
2004-09-01 |
2006-04-13 |
Genvec, Inc. |
Adenoviral vectors able to transduce apcs, potential use in immune response generation
|
CN100428958C
(zh)
*
|
2004-09-06 |
2008-10-29 |
段亚东 |
一种治疗眼病的植入剂
|
US9993558B2
(en)
|
2004-10-01 |
2018-06-12 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
US20080038316A1
(en)
*
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
EP3173072A1
(de)
*
|
2004-10-01 |
2017-05-31 |
Ramscor, Inc. |
Einfach implantierbare wirkstoffzusammensetzungen mit verzögerter freisetzung
|
US8541413B2
(en)
*
|
2004-10-01 |
2013-09-24 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
US7226435B2
(en)
*
|
2004-10-14 |
2007-06-05 |
Alcon, Inc. |
Drug delivery device
|
US20060089590A1
(en)
*
|
2004-10-27 |
2006-04-27 |
John Higuchi |
Methods and devices for sustained in-vivo release of an active agent
|
US20060107555A1
(en)
*
|
2004-11-09 |
2006-05-25 |
Curtis Marc D |
Universal snow plow adapter
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
WO2006086750A1
(en)
|
2005-02-09 |
2006-08-17 |
Macusight, Inc. |
Liquid formulations for treatment of diseases or conditions
|
US20060204548A1
(en)
|
2005-03-01 |
2006-09-14 |
Allergan, Inc. |
Microimplants for ocular administration
|
US7699863B2
(en)
*
|
2005-03-01 |
2010-04-20 |
Tulip Medical Ltd. |
Bioerodible self-deployable intragastric implants
|
US7785291B2
(en)
*
|
2005-03-01 |
2010-08-31 |
Tulip Medical Ltd. |
Bioerodible self-deployable intragastric implants
|
US20060233858A1
(en)
*
|
2005-03-08 |
2006-10-19 |
Allergan, Inc. |
Systems and methods providing targeted intraocular drug delivery
|
US7759312B2
(en)
*
|
2005-03-11 |
2010-07-20 |
Endo Pharmaceuticals Solutions Inc. |
Delivery of dry formulations of octreotide
|
WO2006099288A2
(en)
*
|
2005-03-11 |
2006-09-21 |
Indevus Pharmaceuticals, Inc. |
Controlled release formulations of octreotide
|
WO2006102378A2
(en)
*
|
2005-03-21 |
2006-09-28 |
Macusight, Inc. |
Drug delivery systems for treatment of diseases or conditions
|
US7931909B2
(en)
*
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
US20060258994A1
(en)
*
|
2005-05-12 |
2006-11-16 |
Avery Robert L |
Implantable delivery device for administering pharmacological agents to an internal portion of a body
|
WO2006127592A2
(en)
*
|
2005-05-26 |
2006-11-30 |
Othera Pharmaceuticals, Inc. |
Use of hydroxylamine derivates for inhibiting vitrectomy-induced cataracts
|
EP1919365A2
(de)
*
|
2005-07-13 |
2008-05-14 |
Anthrogenesis Corporation |
Okular-plug aus kollagen-biogewebe aus plazenta
|
AU2006270094A1
(en)
*
|
2005-07-15 |
2007-01-25 |
Chakshu Research Inc. |
Prevention and treatment of ophthalmic complications of diabetes
|
EP1909812A4
(de)
|
2005-07-27 |
2009-11-25 |
Univ Florida |
Kleine verbindungen zur korrektur von protein-missfaltungen und verwendungen davon
|
WO2007019427A2
(en)
*
|
2005-08-08 |
2007-02-15 |
Massachusetts Eye & Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
US20070060887A1
(en)
*
|
2005-08-22 |
2007-03-15 |
Marsh David A |
Ophthalmic injector
|
US8765146B2
(en)
*
|
2005-08-31 |
2014-07-01 |
Genvec, Inc. |
Adenoviral vector-based malaria vaccines
|
JP5122460B2
(ja)
*
|
2005-09-16 |
2013-01-16 |
アラーガン、インコーポレイテッド |
治療薬の眼内輸送のための組成物および方法
|
US8168584B2
(en)
|
2005-10-08 |
2012-05-01 |
Potentia Pharmaceuticals, Inc. |
Methods of treating age-related macular degeneration by compstatin and analogs thereof
|
WO2007047607A2
(en)
|
2005-10-18 |
2007-04-26 |
Allergan, Inc. |
Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues
|
US9067047B2
(en)
*
|
2005-11-09 |
2015-06-30 |
The Invention Science Fund I, Llc |
Injectable controlled release fluid delivery system
|
BRPI0618441B8
(pt)
*
|
2005-11-10 |
2021-07-27 |
Genvec Inc |
vetor adenoviral
|
JP5180834B2
(ja)
|
2005-11-29 |
2013-04-10 |
スミスクライン ビーチャム コーポレーション |
治療方法
|
WO2007084582A2
(en)
|
2006-01-17 |
2007-07-26 |
Forsight Labs, Llc |
Drug delivery treatment device
|
EP3632385A1
(de)
|
2006-01-17 |
2020-04-08 |
Novartis AG |
Glaukombehandlungsvorrichtung
|
US7756524B1
(en)
|
2006-01-31 |
2010-07-13 |
Nextel Communications Inc. |
System and method for partially count-based allocation of vocoder resources
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
EP1993584B1
(de)
|
2006-02-02 |
2012-05-30 |
Allergan, Inc. |
CXCR4-Hemmer-Therapie zur Verwendung bei der Behandlung von Augenerkrankungen
|
JP5528708B2
(ja)
|
2006-02-09 |
2014-06-25 |
参天製薬株式会社 |
安定な製剤ならびにそれらを調製および使用する方法
|
US20070203190A1
(en)
*
|
2006-02-22 |
2007-08-30 |
Ghanshyam Patil |
Hydroxylamines and derivatives for the inhibition of complement activation
|
US20070202186A1
(en)
|
2006-02-22 |
2007-08-30 |
Iscience Interventional Corporation |
Apparatus and formulations for suprachoroidal drug delivery
|
US20080140057A1
(en)
*
|
2006-03-09 |
2008-06-12 |
Searete Llc, A Limited Liability Corporation Of State Of The Delaware |
Injectable controlled release fluid delivery system
|
JP5681362B2
(ja)
*
|
2006-03-14 |
2015-03-04 |
ユニバーシティー オブ サザン カリフォルニア |
治療剤の送達のためのmemsデバイス
|
US8222271B2
(en)
|
2006-03-23 |
2012-07-17 |
Santen Pharmaceutical Co., Ltd. |
Formulations and methods for vascular permeability-related diseases or conditions
|
DK2010096T3
(en)
|
2006-03-31 |
2017-10-02 |
Mati Therapeutics Inc |
NASOLACRIMAL DRAINAGE SYSTEM IMPLANTS FOR PHARMACEUTICAL THERAPY
|
US8676293B2
(en)
*
|
2006-04-13 |
2014-03-18 |
Aecc Enterprises Ltd. |
Devices, systems and methods for measuring and evaluating the motion and function of joint structures and associated muscles, determining suitability for orthopedic intervention, and evaluating efficacy of orthopedic intervention
|
US20070293807A1
(en)
*
|
2006-05-01 |
2007-12-20 |
Lynch Mary G |
Dual drainage pathway shunt device and method for treating glaucoma
|
US20070260203A1
(en)
*
|
2006-05-04 |
2007-11-08 |
Allergan, Inc. |
Vasoactive agent intraocular implant
|
US7811252B2
(en)
*
|
2006-05-17 |
2010-10-12 |
Alcon Research, Ltd. |
Dosage control device
|
US7887521B2
(en)
*
|
2006-05-17 |
2011-02-15 |
Alcon Research, Ltd. |
Ophthalmic injection system
|
US20070270744A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Bruno Dacquay |
Limited Reuse Assembly For Ophthalmic Injection Device
|
US20070270750A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Alcon, Inc. |
Drug delivery device
|
US7674243B2
(en)
*
|
2006-05-17 |
2010-03-09 |
Alcon Inc. |
Ophthalmic injection device using piezoelectric array
|
US20070268340A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Bruno Dacquay |
Ophthalmic Injection System and Method Using Piezoelectric Array
|
US20070270768A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Bruno Dacquay |
Mechanical Linkage Mechanism For Ophthalmic Injection Device
|
US7862540B2
(en)
*
|
2006-05-17 |
2011-01-04 |
Alcon Research, Ltd. |
Ophthalmic injection device using shape memory alloy
|
US8668676B2
(en)
*
|
2006-06-19 |
2014-03-11 |
Allergan, Inc. |
Apparatus and methods for implanting particulate ocular implants
|
US8802128B2
(en)
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8721702B2
(en)
|
2010-11-15 |
2014-05-13 |
Aquesys, Inc. |
Intraocular shunt deployment devices
|
US9095411B2
(en)
|
2010-11-15 |
2015-08-04 |
Aquesys, Inc. |
Devices for deploying intraocular shunts
|
US8308701B2
(en)
|
2010-11-15 |
2012-11-13 |
Aquesys, Inc. |
Methods for deploying intraocular shunts
|
EP2043572B1
(de)
|
2006-06-30 |
2014-12-31 |
Aquesys Inc. |
Vorrichtung für druckablass in einem organ
|
US20120123316A1
(en)
|
2010-11-15 |
2012-05-17 |
Aquesys, Inc. |
Intraocular shunts for placement in the intra-tenon's space
|
US8663303B2
(en)
|
2010-11-15 |
2014-03-04 |
Aquesys, Inc. |
Methods for deploying an intraocular shunt from a deployment device and into an eye
|
US8852256B2
(en)
|
2010-11-15 |
2014-10-07 |
Aquesys, Inc. |
Methods for intraocular shunt placement
|
US10085884B2
(en)
|
2006-06-30 |
2018-10-02 |
Aquesys, Inc. |
Intraocular devices
|
US8911496B2
(en)
|
2006-07-11 |
2014-12-16 |
Refocus Group, Inc. |
Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
|
MX367099B
(es)
|
2006-07-11 |
2019-08-05 |
Refocus Group Inc |
Protesis escleral para tratar presbiopia y otros transtornos del ojo y dispositivos y metodos relacionados.
|
US9039761B2
(en)
*
|
2006-08-04 |
2015-05-26 |
Allergan, Inc. |
Ocular implant delivery assemblies with distal caps
|
CA2661553A1
(en)
*
|
2006-08-23 |
2008-02-28 |
Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services |
Method of treating or preventing oxidative stress-related disease
|
US20100241046A1
(en)
*
|
2006-09-06 |
2010-09-23 |
Innfocus, Llc |
Apparatus, methods and devices for treatment of ocular disorders
|
US20080097379A1
(en)
*
|
2006-09-26 |
2008-04-24 |
Alcon Manufacturing, Ltd. |
Ophthalmic injection method
|
US20080125712A1
(en)
*
|
2006-09-26 |
2008-05-29 |
Alcon Manufacturing, Ltd. |
Ophthalmic injection system
|
US20080097390A1
(en)
*
|
2006-09-27 |
2008-04-24 |
Alcon Manufacturing, Ltd. |
Spring actuated delivery system
|
EP2068828A2
(de)
*
|
2006-09-29 |
2009-06-17 |
SurModics, Inc. |
Biologisch abbaubare augenimplantate und verfahren zur behandlung von augenleiden
|
US20080091178A1
(en)
*
|
2006-10-11 |
2008-04-17 |
Sunalp Murad A |
Device and method for medical records storage in the eye
|
CN102014987A
(zh)
*
|
2006-10-16 |
2011-04-13 |
爱尔康研究有限公司 |
操作带有一次性端部的眼科手持机的方法
|
US20080281292A1
(en)
*
|
2006-10-16 |
2008-11-13 |
Hickingbotham Dyson W |
Retractable Injection Port
|
EP2063829B1
(de)
*
|
2006-10-16 |
2010-12-08 |
Alcon Research, Ltd. |
Universelle aufladbare baugruppe mit eingeschränkter wiederverwendbarkeit für ein ophthalmisches handstück
|
US9022970B2
(en)
*
|
2006-10-16 |
2015-05-05 |
Alcon Research, Ltd. |
Ophthalmic injection device including dosage control device
|
US8586556B2
(en)
*
|
2006-11-03 |
2013-11-19 |
Allergan, Inc. |
Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
|
US8039010B2
(en)
|
2006-11-03 |
2011-10-18 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
|
CA2668954C
(en)
|
2006-11-10 |
2020-09-08 |
Glaukos Corporation |
Uveoscleral shunt and methods for implanting same
|
US20100034808A1
(en)
*
|
2006-11-21 |
2010-02-11 |
Toru Nakazawa |
Compositions and methods for preserving cells of the eye
|
KR20090110295A
(ko)
|
2006-11-22 |
2009-10-21 |
에드넥서스, 어 브리스톨-마이어스 스퀴브 알&디 컴파니 |
Igf-ir을 포함하는 티로신 키나제 수용체에 대한 공학처리된 단백질에 기반한 표적화 치료제
|
US8969415B2
(en)
*
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
WO2008070479A2
(en)
|
2006-12-01 |
2008-06-12 |
Allergan, Inc. |
Method for determining optimum intraocular locations for drug delivery systems
|
WO2008073576A1
(en)
*
|
2006-12-08 |
2008-06-19 |
Alcon, Inc. |
Drug delivery device
|
US8846073B2
(en)
*
|
2006-12-19 |
2014-09-30 |
Allergan, Inc. |
Low temperature processes for making cyclic lipid implants for intraocular use
|
US20090092574A1
(en)
|
2006-12-29 |
2009-04-09 |
Scott Richard W |
Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
|
CA2675022A1
(en)
*
|
2007-01-09 |
2008-07-17 |
Genvec, Inc. |
Adenoviral vector-based malaria vaccines
|
JP4957258B2
(ja)
*
|
2007-01-15 |
2012-06-20 |
富士通株式会社 |
歩数計数装置および歩数計数方法
|
GB0713463D0
(en)
|
2007-07-11 |
2007-08-22 |
Btg Int Ltd |
Modulators of hypoxia inducible factor-1 and related uses
|
US7911053B2
(en)
*
|
2007-04-19 |
2011-03-22 |
Marvell World Trade Ltd. |
Semiconductor packaging with internal wiring bus
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
US8231892B2
(en)
|
2007-05-24 |
2012-07-31 |
Allergan, Inc. |
Biodegradable drug delivery system
|
WO2008157614A2
(en)
*
|
2007-06-21 |
2008-12-24 |
Yale University |
Sustained intraocular delivery of drugs from biodegradable polymeric microparticles
|
US20090018548A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Charles Steven T |
Pneumatically-Powered Intraocular Lens Injection Device with Removable Cartridge
|
US20090018512A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Charles Steven T |
Pneumatically-Powered Ophthalmic Injector
|
EP2173289A4
(de)
|
2007-07-17 |
2010-11-24 |
Transcend Medical Inc |
Augenimplantat mit hydrogelausdehnungsfähigkeiten
|
US7740619B2
(en)
*
|
2007-08-01 |
2010-06-22 |
Alcon Research, Ltd. |
Spring driven ophthalmic injection device with safety actuator lockout feature
|
JP5323073B2
(ja)
*
|
2007-08-02 |
2013-10-23 |
リフォーカス グループ、インコーポレイテッド |
老眼及び他の眼疾患を治療するためのクロスバーを有する強膜プロテーゼ
|
US20090036842A1
(en)
*
|
2007-08-03 |
2009-02-05 |
Raffi Pinedjian |
Consumable Activation Lever For Injection Device
|
US7629768B2
(en)
*
|
2007-08-03 |
2009-12-08 |
Alcon Research, Ltd. |
Easy cleaning C-shaped charging base
|
SG184728A1
(en)
|
2007-09-07 |
2012-10-30 |
Quadra Logic Tech Inc |
Lacrimal implant detection
|
TWI451862B
(zh)
*
|
2007-10-09 |
2014-09-11 |
Alcon Res Ltd |
用於眼睛注射的熱係數驅動藥丸尺寸
|
TWI498136B
(zh)
*
|
2007-10-09 |
2015-09-01 |
Alcon Res Ltd |
用於遞送速率及溫度相依性物質至眼睛的注射器及其製備方法
|
US20090099481A1
(en)
|
2007-10-10 |
2009-04-16 |
Adam Deitz |
Devices, Systems and Methods for Measuring and Evaluating the Motion and Function of Joints and Associated Muscles
|
EP2214608B1
(de)
|
2007-11-08 |
2015-03-04 |
Alimera Sciences, Inc. |
Okulare implantationsvorrichtung
|
ES2718612T3
(es)
|
2007-12-20 |
2019-07-03 |
Evonik Corp |
Procedimiento para preparar micropartículas que tienen un bajo volumen de disolvente residual
|
MX364408B
(es)
|
2007-12-20 |
2019-04-25 |
Univ Southern California |
Aparatos y metodos para suministrar agentes terapeuticos.
|
US20090162417A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Cook Incorporated |
Drug eluting ocular conformer
|
JP2011509120A
(ja)
|
2008-01-03 |
2011-03-24 |
ユニバーシティ オブ サザン カリフォルニア |
埋め込み可能な薬物送達デバイス、及び当該デバイスを補充するための装置および方法
|
US8602959B1
(en)
*
|
2010-05-21 |
2013-12-10 |
Robert Park |
Methods and devices for delivery of radiation to the posterior portion of the eye
|
AU2009213141A1
(en)
|
2008-02-14 |
2009-08-20 |
Bristol-Myers Squibb Company |
Targeted therapeutics based on engineered proteins that bind EGFR
|
US20100152646A1
(en)
*
|
2008-02-29 |
2010-06-17 |
Reshma Girijavallabhan |
Intravitreal injection device and method
|
US20090227938A1
(en)
*
|
2008-03-05 |
2009-09-10 |
Insitu Therapeutics, Inc. |
Wound Closure Devices, Methods of Use, and Kits
|
WO2009137780A2
(en)
*
|
2008-05-08 |
2009-11-12 |
Replenish Pumps, Llc |
Implantable pumps and cannulas therefor
|
WO2009137785A2
(en)
*
|
2008-05-08 |
2009-11-12 |
Replenish Pumps, Llc |
Drug-delivery pumps and methods of manufacture
|
CN104758999B
(zh)
|
2008-05-08 |
2018-08-07 |
迷你泵有限责任公司 |
可植入药物传送装置与用于填充该装置的设备和方法
|
US9849238B2
(en)
|
2008-05-08 |
2017-12-26 |
Minipumps, Llc |
Drug-delivery pump with intelligent control
|
US9095404B2
(en)
|
2008-05-12 |
2015-08-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
WO2009140246A2
(en)
|
2008-05-12 |
2009-11-19 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
US9877973B2
(en)
|
2008-05-12 |
2018-01-30 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
US10064819B2
(en)
|
2008-05-12 |
2018-09-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
PE20091931A1
(es)
|
2008-05-22 |
2009-12-31 |
Bristol Myers Squibb Co |
Proteinas de dominio de armazon basadas en fibronectina multivalentes
|
ES2640867T3
(es)
|
2008-06-25 |
2017-11-07 |
Novartis Ag |
Implante ocular con capacidad de cambio de forma
|
US8080550B2
(en)
|
2008-08-01 |
2011-12-20 |
Alpha Synergy Development, Inc. |
Anesthetic compositions and methods of use
|
EP2334686B1
(de)
|
2008-08-28 |
2019-02-27 |
President and Fellows of Harvard College |
Cortistatin-analoga und ihre synthese
|
US20100121441A1
(en)
*
|
2008-11-10 |
2010-05-13 |
Nabil Jabbour |
Surgical implant and method
|
US9095506B2
(en)
|
2008-11-17 |
2015-08-04 |
Allergan, Inc. |
Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
|
US8034813B2
(en)
|
2008-11-18 |
2011-10-11 |
Bausch & Lomb Incorporated |
Polymorphs of brimonidine pamoate
|
US8551167B2
(en)
|
2008-11-20 |
2013-10-08 |
Insight Innovations, Llc |
Intraocular implant cell migration inhibition system
|
US20120232649A1
(en)
|
2008-11-20 |
2012-09-13 |
Insight Innovations, Llc |
Intraocular Lens Cell Migration Inhibition System
|
US9943402B2
(en)
|
2008-11-20 |
2018-04-17 |
Insight Innovations, Llc |
Micropatterned intraocular implant
|
US20110230963A1
(en)
*
|
2008-11-20 |
2011-09-22 |
Insight Innovations, Llc |
Biocompatible biodegradable intraocular implant system
|
TWI496582B
(zh)
|
2008-11-24 |
2015-08-21 |
必治妥美雅史谷比公司 |
雙重專一性之egfr/igfir結合分子
|
US20100158980A1
(en)
|
2008-12-18 |
2010-06-24 |
Casey Kopczynski |
Drug delivery devices for delivery of therapeutic agents
|
US8545554B2
(en)
*
|
2009-01-16 |
2013-10-01 |
Allergan, Inc. |
Intraocular injector
|
US8425473B2
(en)
|
2009-01-23 |
2013-04-23 |
Iscience Interventional Corporation |
Subretinal access device
|
US20100191177A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Iscience Interventional Corporation |
Device for aspirating fluids
|
JP5524983B2
(ja)
|
2009-01-28 |
2014-06-18 |
トランセンド・メディカル・インコーポレイテッド |
インプラントシステム
|
CA2757037C
(en)
|
2009-01-29 |
2019-08-06 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
US9636255B2
(en)
|
2009-02-13 |
2017-05-02 |
Dose Medical Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
WO2010096561A1
(en)
|
2009-02-18 |
2010-08-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Synthetic hiv/siv gag proteins and uses thereof
|
JP5342301B2
(ja)
*
|
2009-03-30 |
2013-11-13 |
三菱重工業株式会社 |
太陽光集光受熱器
|
US8632511B2
(en)
|
2009-05-06 |
2014-01-21 |
Alcon Research, Ltd. |
Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
JP5695035B2
(ja)
|
2009-06-03 |
2015-04-01 |
フォーサイト・ビジョン5・インコーポレイテッドForsight Vision5,Inc. |
前眼部薬物供給
|
IN2012DN00352A
(de)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
US8987241B2
(en)
|
2009-06-19 |
2015-03-24 |
Altos Vision Limited |
Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
|
EP2467797B1
(de)
*
|
2009-08-18 |
2017-07-19 |
MiniPumps, LLC |
Elektrolytische arzneimittelverabreichungspumpe mit adaptiver steuerung
|
US9605844B2
(en)
*
|
2009-09-01 |
2017-03-28 |
Cree, Inc. |
Lighting device with heat dissipation elements
|
WO2011038236A2
(en)
|
2009-09-25 |
2011-03-31 |
Ortho Kinematics, Inc. |
Systems and devices for an integrated imaging system with real-time feedback loops and methods therefor
|
WO2011039648A1
(en)
|
2009-09-30 |
2011-04-07 |
Glaxo Wellcome Manufacturing Pte Ltd. |
Methods of administration and treatment
|
WO2011047316A1
(en)
|
2009-10-16 |
2011-04-21 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Nucleic acid sequences encoding expandable hiv mosaic proteins
|
BR112012010026B8
(pt)
*
|
2009-10-30 |
2021-02-02 |
Aton Pharma Inc |
método de formação de um dispositivo de liberação ocular e dispositivo de liberação ocular
|
WO2011057254A2
(en)
|
2009-11-09 |
2011-05-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Simian adenoviral vector-based vaccines
|
EP2498783B1
(de)
|
2009-11-09 |
2018-08-22 |
Allergan, Inc. |
Zusammensetzungen und verfahren zur stimulation des haarwuchses
|
AU2010319398B2
(en)
|
2009-11-13 |
2014-06-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
|
US8177747B2
(en)
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
US8529492B2
(en)
|
2009-12-23 |
2013-09-10 |
Trascend Medical, Inc. |
Drug delivery devices and methods
|
CN102740830A
(zh)
*
|
2009-12-23 |
2012-10-17 |
普西维达公司 |
缓释递送装置
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
EP2538965B1
(de)
|
2010-02-25 |
2017-04-12 |
Schepens Eye Research Institute |
Therapeutische zusammensetzungen zur behandlung des syndroms des trockenen auges
|
US9682133B2
(en)
|
2010-03-17 |
2017-06-20 |
Cornell University |
Disrupted adenovirus-based vaccine against drugs of abuse
|
EP2547660B1
(de)
|
2010-03-19 |
2015-01-07 |
The United States Of America, As Represented By The Secretary, Department of Health and Human Services |
Nitroxyl (hno)-freisetzende verbindungen und ihre verwendung zur behandlung von erkrankungen
|
AU2011242465B2
(en)
|
2010-04-23 |
2017-01-19 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
|
EP2383286A1
(de)
|
2010-04-30 |
2011-11-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren und Zusammensetzungen zur Behandlung von degenerativen Netzhauterkrankungen
|
SI2563813T1
(sl)
|
2010-04-30 |
2015-12-31 |
Alexion Pharmaceuticals, Inc. |
Protitelesa anti-C5A in postopki uporabe protiteles
|
WO2011146483A1
(en)
*
|
2010-05-17 |
2011-11-24 |
Aerie Pharmaceuticals, Inc. |
Drug delivery devices for delivery of ocular therapeutic agents
|
WO2011150133A2
(en)
|
2010-05-26 |
2011-12-01 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold proteins having improved stability
|
AU2011285548B2
(en)
|
2010-08-05 |
2014-02-06 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
RS61601B1
(sr)
|
2010-08-05 |
2021-04-29 |
Forsight Vision4 Inc |
Aparati za ubrizgavanje za dostavu leka
|
RS62540B1
(sr)
|
2010-08-05 |
2021-12-31 |
Forsight Vision4 Inc |
Aparat za lečenje oka
|
WO2012021730A2
(en)
|
2010-08-11 |
2012-02-16 |
Genvec, Inc. |
Respiratory syncytial virus (rsv) vaccine
|
US20120271272A1
(en)
|
2010-10-15 |
2012-10-25 |
Iscience Interventional Corporation |
Device for ocular access
|
WO2012061045A2
(en)
|
2010-11-01 |
2012-05-10 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving retinal ganglion cells
|
US20160256317A1
(en)
|
2010-11-15 |
2016-09-08 |
Aquesys, Inc. |
Methods for implanting intraocular shunts
|
AU2011329656B2
(en)
|
2010-11-19 |
2017-01-05 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
US9668915B2
(en)
|
2010-11-24 |
2017-06-06 |
Dose Medical Corporation |
Drug eluting ocular implant
|
CA2821110A1
(en)
|
2010-12-13 |
2012-06-21 |
Ortho Kinematics, Inc. |
Methods, systems and devices for clinical data reporting and surgical navigation
|
WO2012083297A2
(en)
|
2010-12-17 |
2012-06-21 |
Genvec, Inc. |
Adenoviral vectors with modified hexon regions
|
EP2654786B1
(de)
|
2010-12-20 |
2019-02-20 |
GenVec, Inc. |
Auf adenovirusvektor basierender impfstoff gegen denguefieber
|
WO2012114138A1
(fr)
|
2011-02-21 |
2012-08-30 |
Cerebel-Invest Sa |
Implants biodégradables pour la libération contrôlée sous-conjonctivale d'une molécule active
|
US9603997B2
(en)
|
2011-03-14 |
2017-03-28 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
US10286146B2
(en)
|
2011-03-14 |
2019-05-14 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
US9919099B2
(en)
|
2011-03-14 |
2018-03-20 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
US8992503B2
(en)
|
2011-03-27 |
2015-03-31 |
Microsert Ltd. |
Miniature implanted drug delivery devices and inserter systems for introducing such devices
|
US9012647B2
(en)
|
2011-04-07 |
2015-04-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treatment and prevention of diseases or disorders
|
US8889672B2
(en)
|
2011-04-29 |
2014-11-18 |
The Regents Of The University Of Michigan |
Compounds, formulations, and methods of protein kinase C inhibition
|
WO2012162428A1
(en)
|
2011-05-23 |
2012-11-29 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Prime-boost vaccination for viral infection
|
WO2012167223A1
(en)
|
2011-06-02 |
2012-12-06 |
Massachusetts Institute Of Technology |
Modified alginates for cell encapsulation and cell therapy
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
US9133082B2
(en)
|
2011-06-14 |
2015-09-15 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
WO2013003467A2
(en)
|
2011-06-27 |
2013-01-03 |
Massachusetts Eye And Ear Infirmary |
Methods for treating ocular inflammatory disorders
|
EP2726016B1
(de)
|
2011-06-28 |
2023-07-19 |
ForSight Vision4, Inc. |
Vorrichtung zum sammeln einer flüssigkeitsprobe aus einer reservoirkammer einer therapeutischen vorrichtung für das auge
|
WO2013025840A1
(en)
|
2011-08-15 |
2013-02-21 |
Massachusetts Eye And Ear Infirmary |
Methods for preserving photoreceptor cell viability following retinal detachment
|
EP3659495B1
(de)
|
2011-09-13 |
2022-12-14 |
Dose Medical Corporation |
Intraokularer physiologischer sensor
|
WO2013040426A2
(en)
|
2011-09-14 |
2013-03-21 |
Forsight Labs, Llc |
Ocular insert apparatus and methods
|
WO2013040247A2
(en)
|
2011-09-16 |
2013-03-21 |
Forsight Vision4, Inc. |
Fluid exchange apparatus and methods
|
JP2014528465A
(ja)
|
2011-10-12 |
2014-10-27 |
アセンディス ファーマ オフサルモロジー ディヴィジョン エー/エス |
眼の状態の予防及び治療
|
AU2012325341B2
(en)
|
2011-10-19 |
2017-01-05 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
CA2888805C
(en)
|
2011-10-21 |
2020-07-14 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for promoting axon regeneration and nerve function
|
JP6126118B2
(ja)
|
2011-11-30 |
2017-05-10 |
ビカム ファーマスーティカルス,インコーポレイテッド |
オプシン結合性リガンド、組成物、及び使用方法
|
WO2013081642A1
(en)
|
2011-12-01 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
US10080682B2
(en)
|
2011-12-08 |
2018-09-25 |
Aquesys, Inc. |
Intrascleral shunt placement
|
US9610195B2
(en)
|
2013-02-27 |
2017-04-04 |
Aquesys, Inc. |
Intraocular shunt implantation methods and devices
|
US8765210B2
(en)
|
2011-12-08 |
2014-07-01 |
Aquesys, Inc. |
Systems and methods for making gelatin shunts
|
US8852136B2
(en)
|
2011-12-08 |
2014-10-07 |
Aquesys, Inc. |
Methods for placing a shunt into the intra-scleral space
|
US9808373B2
(en)
|
2013-06-28 |
2017-11-07 |
Aquesys, Inc. |
Intraocular shunt implantation
|
US9241829B2
(en)
*
|
2011-12-20 |
2016-01-26 |
Abbott Medical Optics Inc. |
Implantable intraocular drug delivery apparatus, system and method
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
WO2013124477A1
(en)
|
2012-02-24 |
2013-08-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions for treatment of retinal degenerative diseases
|
US10093947B2
(en)
|
2012-02-28 |
2018-10-09 |
Cornell University |
AAV-directed persistent expression of an anti-nicotine antibody gene for smoking cessation
|
WO2013154744A1
(en)
|
2012-04-13 |
2013-10-17 |
Cornell University |
Development of a highly efficient second generation nicotine-conjugate vaccine to treat nicotine addiction
|
US10085633B2
(en)
|
2012-04-19 |
2018-10-02 |
Novartis Ag |
Direct visualization system for glaucoma treatment
|
US9241832B2
(en)
|
2012-04-24 |
2016-01-26 |
Transcend Medical, Inc. |
Delivery system for ocular implant
|
WO2013180967A1
(en)
|
2012-05-29 |
2013-12-05 |
Genvec, Inc. |
Herpes simplex virus vaccine
|
JP6549482B2
(ja)
|
2012-06-01 |
2019-07-24 |
サーモディクス,インコーポレイテッド |
バルーンカテーテルをコーティングするための装置および方法
|
US9827401B2
(en)
|
2012-06-01 |
2017-11-28 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
US10507127B2
(en)
|
2012-06-07 |
2019-12-17 |
Epitomee Medical Ltd. |
Expandable device
|
RU2650203C2
(ru)
|
2012-09-17 |
2018-04-11 |
Новартис Аг |
Устройства расширяющихся офтальмологических имплантатов
|
TWI663985B
(zh)
|
2012-09-27 |
2019-07-01 |
美商歐樂根公司 |
用於持續釋放蛋白質之可生物降解的藥物傳遞系統
|
WO2014066775A1
(en)
|
2012-10-26 |
2014-05-01 |
Forsight Vision5, Inc. |
Ophthalmic system for sustained release of drug to eye
|
CN104884049A
(zh)
|
2012-11-08 |
2015-09-02 |
克莱尔塞德生物医学股份有限公司 |
用于在人类受试者中治疗眼部疾病的方法和装置
|
US9763829B2
(en)
|
2012-11-14 |
2017-09-19 |
Novartis Ag |
Flow promoting ocular implant
|
DK3660033T5
(da)
|
2012-11-15 |
2022-06-27 |
Apellis Pharmaceuticals Inc |
Langtidsvirkende compstatinanaloger og tilhørende sammensætninger og fremgangsmåder
|
WO2014093270A1
(en)
|
2012-12-10 |
2014-06-19 |
Virginia Commonwealth University |
Tropism modified cancer terminator virus (ad.5/3 ctv;ad.5/3-ctv-m7)
|
EP2953950B1
(de)
|
2013-02-11 |
2021-01-13 |
The Regents of The University of California |
Zusammensetzungen und verfahren zur behandlung neurodegenerativer erkrankungen
|
CA2901280A1
(en)
|
2013-02-15 |
2014-08-21 |
Allergan, Inc. |
Sustained drug delivery implant
|
PT2956476T
(pt)
|
2013-02-18 |
2020-02-21 |
Vegenics Pty Ltd |
Moléculas de ligação e usos destas
|
US10159600B2
(en)
|
2013-02-19 |
2018-12-25 |
Aquesys, Inc. |
Adjustable intraocular flow regulation
|
US9125723B2
(en)
|
2013-02-19 |
2015-09-08 |
Aquesys, Inc. |
Adjustable glaucoma implant
|
EP2968613B1
(de)
|
2013-03-11 |
2019-09-11 |
University of Florida Research Foundation, Inc. |
Freisetzung von card-protein zur behandlung von augenentzündungen
|
EP2970145B1
(de)
|
2013-03-11 |
2020-05-06 |
The Broad Institute, Inc. |
Verbindungen und zusammensetzungen zur behandlung von krebs
|
US9730638B2
(en)
|
2013-03-13 |
2017-08-15 |
Glaukos Corporation |
Intraocular physiological sensor
|
CA2905496A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
US10308687B2
(en)
|
2013-03-15 |
2019-06-04 |
Apellis Pharmaceuticals, Inc. |
Cell-penetrating compstatin analogs and uses thereof
|
US9592151B2
(en)
|
2013-03-15 |
2017-03-14 |
Glaukos Corporation |
Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
|
US10517759B2
(en)
|
2013-03-15 |
2019-12-31 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
AU2014241163B2
(en)
|
2013-03-28 |
2018-09-27 |
Forsight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
US9987163B2
(en)
|
2013-04-16 |
2018-06-05 |
Novartis Ag |
Device for dispensing intraocular substances
|
JP6340673B2
(ja)
|
2013-05-02 |
2018-06-13 |
レティナ ファウンデーション オブ ザ サウスウエストRetina Foundation Of The Southwest |
二層型眼用インプラント
|
AU2014259694B2
(en)
|
2013-05-03 |
2018-11-08 |
Clearside Biomedical, Inc. |
Apparatus and methods for ocular injection
|
EP2994758B1
(de)
|
2013-05-08 |
2017-12-20 |
Opthea Limited |
Biomarker für altersbedingte makuladegeneration (amd)
|
US20160355573A1
(en)
|
2013-09-05 |
2016-12-08 |
Cornell University |
Gene therapy for alzheimer's and other neurodegenerative diseases and conditions
|
BR112016009575B1
(pt)
|
2013-10-31 |
2022-12-13 |
Allergan, Inc |
Implante intraocular biodegradável, uso do mesmo, aparelho para liberar um implante intraocular biodegradável e método para preparar um implante intraocular biodegradável
|
US10087224B2
(en)
|
2013-11-01 |
2018-10-02 |
Cornell University |
Gene therapy for Alzheimer's and other neurodegenerative diseases and conditions
|
AU2014346559B2
(en)
|
2013-11-07 |
2020-07-09 |
Editas Medicine,Inc. |
CRISPR-related methods and compositions with governing gRNAs
|
US9585790B2
(en)
|
2013-11-14 |
2017-03-07 |
Aquesys, Inc. |
Intraocular shunt inserter
|
WO2015071427A1
(en)
|
2013-11-14 |
2015-05-21 |
Eyed Pharma |
Eye device
|
WO2015083171A1
(en)
|
2013-12-05 |
2015-06-11 |
Tulip Medical Ltd. |
Retentive devices and systems for in-situ release of pharmaceutical active agents
|
US10010447B2
(en)
|
2013-12-18 |
2018-07-03 |
Novartis Ag |
Systems and methods for subretinal delivery of therapeutic agents
|
AU2014369834B2
(en)
|
2013-12-24 |
2018-12-20 |
President And Fellows Of Harvard College |
Cortistatin analogues and syntheses and uses thereof
|
US10143703B2
(en)
|
2014-01-02 |
2018-12-04 |
Massachusetts Eye And Ear Infirmary |
Treating ocular neovascularization
|
WO2015112739A1
(en)
|
2014-01-22 |
2015-07-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds and method for treating parp1-deficient cancers
|
HRP20220759T1
(hr)
|
2014-02-11 |
2022-09-02 |
Mitokinin, Inc. |
Pripravci i postupci koji ih koriste za liječenje neurodegenerativne i mitohondrijske bolesti
|
WO2015134812A1
(en)
|
2014-03-05 |
2015-09-11 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating usher syndrome and retinitis pigmentosa
|
NZ631007A
(en)
|
2014-03-07 |
2015-10-30 |
Alexion Pharma Inc |
Anti-c5 antibodies having improved pharmacokinetics
|
DK3116997T3
(da)
|
2014-03-10 |
2019-08-19 |
Editas Medicine Inc |
Crispr/cas-relaterede fremgangsmåder og sammensætninger til behandling af lebers kongenitale amaurose 10 (lca10)
|
US11339437B2
(en)
|
2014-03-10 |
2022-05-24 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
US11141493B2
(en)
|
2014-03-10 |
2021-10-12 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
WO2015184173A1
(en)
|
2014-05-29 |
2015-12-03 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
WO2016011191A1
(en)
|
2014-07-15 |
2016-01-21 |
Forsight Vision4, Inc. |
Ocular implant delivery device and method
|
KR20170055960A
(ko)
|
2014-08-01 |
2017-05-22 |
메사추세츠 인스티튜트 오브 테크놀로지 |
항-섬유 물질 및 응용을 위한 변형된 알기네이트
|
SG11201700943TA
(en)
|
2014-08-08 |
2017-03-30 |
Forsight Vision4 Inc |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
CA2967330A1
(en)
|
2014-11-10 |
2016-05-19 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and methods of use
|
FR3028410A1
(fr)
|
2014-11-18 |
2016-05-20 |
Pierre Coulon |
Implant capsulaire multifonctionnel
|
CA2982213C
(en)
|
2015-04-09 |
2022-10-18 |
Cornell University |
Gene therapy to prevent reactions to allergens
|
US20160296532A1
(en)
|
2015-04-13 |
2016-10-13 |
Forsight Vision5, Inc. |
Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
|
EP3294298A4
(de)
|
2015-05-08 |
2018-10-17 |
President and Fellows of Harvard College |
Cortistatin-analoga, synthese und verwendungen
|
CA2985786A1
(en)
|
2015-05-12 |
2016-11-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Aav isolate and fusion protein comprising nerve growth factor signal peptide and parathyroid hormone
|
MX2017014966A
(es)
|
2015-05-28 |
2018-08-15 |
Univ Cornell |
Liberación de c1ei mediada por virus adenoasociado como terapia para el angioedema.
|
BR112017025859A2
(pt)
|
2015-06-03 |
2018-08-14 |
Aquesys, Inc. |
colocação de shunt intraocular ab externo
|
US20160354161A1
(en)
|
2015-06-05 |
2016-12-08 |
Ortho Kinematics, Inc. |
Methods for data processing for intra-operative navigation systems
|
EP3316889A4
(de)
|
2015-07-01 |
2018-11-14 |
President and Fellows of Harvard College |
Cortistatin-analoga sowie synthese und verwendungen davon
|
RS63319B1
(sr)
|
2015-09-02 |
2022-07-29 |
Trevena Inc |
Jedinjenja koja modulišu delta-opioidni receptor, koja sadrže 6-člani aza-heterociklik, postupci njihove upotrebe i spravljanja
|
WO2017040853A1
(en)
|
2015-09-02 |
2017-03-09 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
US10182939B2
(en)
|
2015-09-16 |
2019-01-22 |
Novartis Ag |
Hydraulic injector and methods for intra-ocular lens insertion
|
US11564833B2
(en)
|
2015-09-25 |
2023-01-31 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
DK3359555T3
(da)
|
2015-10-07 |
2024-03-25 |
Apellis Pharmaceuticals Inc |
Doseringsplaner
|
JP7408284B2
(ja)
|
2015-10-30 |
2024-01-05 |
エディタス・メディシン、インコーポレイテッド |
単純ヘルペスウイルスを治療するためのcrispr/cas関連方法及び組成物
|
MX2018005420A
(es)
|
2015-11-01 |
2018-06-06 |
Massachusetts Inst Technology |
Alginatos modificados para materiales anti-fibroticos y aplicaciones.
|
US11180538B2
(en)
|
2015-11-13 |
2021-11-23 |
University Of Utah Research Foundation |
Combinatorial gene construct and non-viral delivery for anti-obesity
|
CN113069681B
(zh)
|
2015-11-20 |
2022-12-23 |
弗赛特影像4股份有限公司 |
制造用于缓释药物递送的治疗装置的方法
|
US10390901B2
(en)
|
2016-02-10 |
2019-08-27 |
Clearside Biomedical, Inc. |
Ocular injection kit, packaging, and methods of use
|
CA3014774A1
(en)
|
2016-02-17 |
2017-08-24 |
Children's Medical Center Corporation |
Ffa1 (gpr40) as a therapeutic target for neural angiogenesis diseases or disorders
|
WO2017173327A1
(en)
|
2016-03-31 |
2017-10-05 |
The Schepens Eye Research Institute, Inc. |
Endomucin inhibitor as an anti-angiogenic agent
|
ES2837524T3
(es)
|
2016-04-05 |
2021-06-30 |
Forsight Vision4 Inc |
Dispositivos de administración de fármacos oculares implantables
|
WO2017184881A1
(en)
|
2016-04-20 |
2017-10-26 |
Harold Alexander Heitzmann |
Bioresorbable ocular drug delivery device
|
JP2019514581A
(ja)
|
2016-05-02 |
2019-06-06 |
クリアサイド バイオメディカル,インコーポレイテッド |
眼の薬物送達のためのシステムおよび方法
|
US10501744B2
(en)
|
2016-05-04 |
2019-12-10 |
Indiana University Research And Technology Corporation |
Presentation of bioactive proteins
|
WO2017210627A1
(en)
|
2016-06-02 |
2017-12-07 |
Aquesys, Inc. |
Intraocular drug delivery
|
AU2017283463A1
(en)
|
2016-06-13 |
2019-01-17 |
Massachusetts Institute Of Technology |
Biocompatible zwitterionic polymer coatings and hydrogels for reducing foreign body response and fibrosis
|
AU2017305404B2
(en)
|
2016-08-02 |
2023-11-30 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290 associated disease
|
IL305537A
(en)
|
2016-08-12 |
2023-10-01 |
Clearside Biomedical Inc |
Devices and methods for adjusting the insertion depth of a drug administration needle
|
US11040019B2
(en)
|
2016-08-19 |
2021-06-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration
|
EP3532616A1
(de)
|
2016-10-28 |
2019-09-04 |
Editas Medicine, Inc. |
Verfahren im zusammenhang mit crispr/cas und zusammensetzungen zur behandlung des herpes-simplex-virus
|
WO2018093797A1
(en)
|
2016-11-15 |
2018-05-24 |
The Schepens Eye Research Institute, Inc. |
Compositions and methods for the treatment of aberrant angiogenesis
|
KR20190122205A
(ko)
*
|
2016-12-29 |
2019-10-29 |
퓨어 래티오스 홀딩스, 인크. |
모듈식 경피 전달 시스템, 및 관련 제조 및 사용 방법
|
EP3582779B1
(de)
|
2017-02-17 |
2024-04-17 |
Trevena, Inc. |
5-gliedrige heterozyklen mit delta-opioidrezeptor-modulierenden verbindungen, verfahren zur herstellung und verwendung davon
|
KR20190117658A
(ko)
|
2017-02-17 |
2019-10-16 |
트레베나, 인코포레이티드. |
7-원 아자-헤테로고리 함유 델타-오피오이드 수용체 조절 화합물, 및 그의 사용 및 제조 방법
|
CA3059304A1
(en)
|
2017-04-07 |
2018-10-11 |
Apellis Pharmaceuticals, Inc. |
Dosing regimens and related compositions and methods
|
EP3618841B1
(de)
|
2017-05-05 |
2023-03-22 |
University of Pittsburgh - of The Commonwealth System of Higher Education |
Okulare anwendungen von matrixgebundenen vesikeln (mbvs)
|
WO2018220444A2
(en)
*
|
2017-05-30 |
2018-12-06 |
Eximore Ltd. |
Compositions and methods for treating dry eye syndrome delivering antibiotic macrolide
|
US11414419B2
(en)
|
2017-06-21 |
2022-08-16 |
Mitokinin, Inc. |
Substituted purines for the treatment of neurodegenerative and mitochondrial diseases
|
AU2018300237A1
(en)
|
2017-07-14 |
2020-01-16 |
Cytomx Therapeutics, Inc. |
Anti-CD166 antibodies and uses thereof
|
WO2019023564A1
(en)
|
2017-07-27 |
2019-01-31 |
Alexion Pharmaceutical, Inc. |
ANTI-C5 ANTIBODY FORMULATIONS WITH HIGH CONCENTRATION
|
CN111372598A
(zh)
|
2017-08-11 |
2020-07-03 |
联合生物科技公司 |
使用消除衰老细胞的药剂治疗诸如黄斑变性,青光眼,和糖尿病性视网膜病变等眼科状况
|
BR112020006601A2
(pt)
|
2017-10-02 |
2020-12-08 |
Genedit Inc. |
Rna guia de cpf1 modificado
|
US11260048B2
(en)
|
2017-10-03 |
2022-03-01 |
The Schepens Eye Research Institute, Inc. |
Compounds and compositions for inhibiting retinal pigment epithelium degeneration and methods using the same
|
WO2019079572A1
(en)
|
2017-10-18 |
2019-04-25 |
Washington University |
NEGATIVE DOMINANT SARM1 MOLECULES AS A THERAPEUTIC STRATEGY FOR NEURODEGENERATIVE DISEASES OR DISORDERS
|
WO2019090309A1
(en)
|
2017-11-06 |
2019-05-09 |
Massachusetts Institute Of Technology |
Anti-inflammatory coatings to improve biocompatibility of neurological implants
|
US11246753B2
(en)
|
2017-11-08 |
2022-02-15 |
Aquesys, Inc. |
Manually adjustable intraocular flow regulation
|
CA3082643A1
(en)
|
2017-11-14 |
2019-05-23 |
The Schepens Eye Research Institute, Inc. |
Runx1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition
|
CN111655206B
(zh)
|
2017-11-21 |
2022-10-14 |
弗赛特影像4股份有限公司 |
用于可扩展端口递送系统的流体交换装置及使用方法
|
BR112020012830A2
(pt)
|
2017-12-29 |
2021-01-26 |
Cornell University |
terapia genética para distúrbios eosinofílicos
|
WO2019161378A1
(en)
|
2018-02-19 |
2019-08-22 |
University Of Miami |
Cyclophosphamide for treating ophthalmic inflammation
|
EP3758736A1
(de)
|
2018-03-02 |
2021-01-06 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Verwendung von il-34 zur behandlung von retinaler entzündung und neurodegeneration
|
US11135089B2
(en)
|
2018-03-09 |
2021-10-05 |
Aquesys, Inc. |
Intraocular shunt inserter
|
US10952898B2
(en)
|
2018-03-09 |
2021-03-23 |
Aquesys, Inc. |
Intraocular shunt inserter
|
DE102018106217A1
(de)
|
2018-03-16 |
2019-09-19 |
Amw Gmbh |
Applikator
|
AU2019249162A1
(en)
|
2018-04-03 |
2020-11-26 |
Cornell University |
Gene therapy for oxidative stress
|
US11821009B2
(en)
|
2018-05-15 |
2023-11-21 |
Cornell University |
Genetic modification of the AAV capsid resulting in altered tropism and enhanced vector delivery
|
CA3108324A1
(en)
|
2018-07-31 |
2020-02-06 |
Cornell University |
Gene therapy methods to control organ function
|
US11628466B2
(en)
|
2018-11-29 |
2023-04-18 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
BR112021012172A2
(pt)
|
2018-12-12 |
2021-08-31 |
Kite Pharma, Inc. |
Receptores de antígenos quiméricos e de célula t e métodos de uso
|
KR20210133993A
(ko)
|
2019-02-25 |
2021-11-08 |
에디타스 메디신, 인코포레이티드 |
Rho-연관 상염색체-우성 망막색소변성증(adrp)을 치료하기 위한 crispr/rna-가이드 뉴클레아제-관련 방법 및 조성물
|
US11819590B2
(en)
|
2019-05-13 |
2023-11-21 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
KR20220036946A
(ko)
|
2019-06-27 |
2022-03-23 |
레이어바이오 인크. |
안구 장치 전달 방법 및 시스템
|
EP4007609A1
(de)
|
2019-08-01 |
2022-06-08 |
Cornell University |
Gezielte gentherapie zur behandlung von neurologischen erkrankungen
|
WO2021062012A1
(en)
|
2019-09-25 |
2021-04-01 |
Emory University |
Use of klk10 and engineered derivatizations thereof
|
WO2021076794A1
(en)
|
2019-10-15 |
2021-04-22 |
Cornell University |
Methods for modulating level of expression from gene therapy expression cassette
|
US11471426B2
(en)
|
2019-10-16 |
2022-10-18 |
American River Nutrition, Llc |
Compositions comprising quinone and/or quinol and methods of preparations and use thereof
|
KR20220082050A
(ko)
|
2019-10-16 |
2022-06-16 |
코넬 유니버시티 |
알츠하이머병에 대한 유전자 요법
|
US20230001017A1
(en)
|
2019-10-28 |
2023-01-05 |
University Of Lowa Research Foundation |
Formulation for delivery of lubricin gene
|
US20230044351A1
(en)
|
2019-11-25 |
2023-02-09 |
Cornell University |
Apoe gene therapy
|
AU2021208631A1
(en)
|
2020-01-17 |
2022-07-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Gene therapy for treatment of CRX-autosomal dominant retinopathies
|
EP4118202A1
(de)
|
2020-03-20 |
2023-01-18 |
Athanor Biosciences, Inc. |
Impfstoffe auf bakteriophagenbasis und manipulierter bakteriophagen
|
CA3179541A1
(en)
|
2020-04-05 |
2021-10-14 |
Athanor Biosciences, Inc. |
Bacteriophage-based antibodies and protein-based binders
|
JP2023523931A
(ja)
|
2020-04-23 |
2023-06-08 |
ユニヴァーシティ オブ アイオワ リサーチ ファウンデーション |
Gperタンパク質分解ターゲティングキメラ
|
CA3176425A1
(en)
|
2020-04-24 |
2021-10-28 |
Millennium Pharmaceuticals, Inc. |
Anti-cd19 antibodies and uses thereof
|
AU2021300425A1
(en)
|
2020-07-02 |
2023-02-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cyclic compounds for use in treating retinal degeneration
|
US20230374483A1
(en)
|
2020-07-08 |
2023-11-23 |
Regents Of The University Of Minnesota |
Modified hexosaminidase and uses thereof
|
WO2022036104A1
(en)
|
2020-08-12 |
2022-02-17 |
University Of Iowa Research Foundation |
Insulin sensitizers for the treatment of diabetes mellitus
|
US20230293678A1
(en)
|
2020-08-21 |
2023-09-21 |
Aliasger K. Salem |
Cationic nanoparticle adjuvants
|
US20230414787A1
(en)
|
2020-08-27 |
2023-12-28 |
University Of Iowa Research Foundation |
Gene knock-out for treatment of glaucoma
|
WO2022125963A1
(en)
|
2020-12-11 |
2022-06-16 |
University Of Iowa Research Foundation |
Compositions comprising molecules for cystic fibrosis treatment
|
JP2024515066A
(ja)
|
2021-04-09 |
2024-04-04 |
武田薬品工業株式会社 |
補体因子dを標的とする抗体及びその使用
|
EP4323522A1
(de)
|
2021-04-16 |
2024-02-21 |
Editas Medicine, Inc. |
Crispr/rna-geführte nukleaseassoziierte verfahren und zusammensetzungen zur behandlung von rho-assoziierter autosomal-dominanter retinitis pigmentosa (adrp)
|
AR125451A1
(es)
|
2021-04-26 |
2023-07-19 |
Millennium Pharm Inc |
Anticuerpos anti-clec12a y usos de los mismos
|
EP4330283A1
(de)
|
2021-04-26 |
2024-03-06 |
Millennium Pharmaceuticals, Inc. |
Anti-adgre2-antikörper und verwendungen davon
|
EP4340894A1
(de)
|
2021-05-21 |
2024-03-27 |
University Of Iowa Research Foundation |
Antioxidationsmittelhaltige partikel und verfahren zur verwendung
|
WO2022271951A1
(en)
|
2021-06-23 |
2022-12-29 |
University Of Iowa Research Foundation |
Sustained release formulations comprising a selective androgen receptor modulator
|
KR20240026984A
(ko)
|
2021-07-07 |
2024-02-29 |
제넨테크, 인크. |
로드 삽입기 시스템 및 방법
|
WO2023068382A2
(en)
|
2021-10-20 |
2023-04-27 |
Takeda Pharmaceutical Company Limited |
Compositions targeting bcma and methods of use thereof
|
WO2023105417A1
(en)
|
2021-12-06 |
2023-06-15 |
Breye Therapeutics Aps |
Danegaptide formulation for applicatoin in the eye
|
WO2023130022A2
(en)
|
2021-12-29 |
2023-07-06 |
University Of Iowa Research Foundation |
Cystatin rna compositions for tissue engineering
|
WO2023164727A1
(en)
|
2022-02-28 |
2023-08-31 |
University Of Iowa Research Foundation |
A-fabp antibodies for diagnosis and treatment of obesity-associated diseases
|
US20230346862A1
(en)
|
2022-05-02 |
2023-11-02 |
Athanor Biosciences, Inc. |
Cancer eradicating - bio-nanoparticles (ce-bnp)
|
WO2023215560A1
(en)
|
2022-05-05 |
2023-11-09 |
Atoosa Corporation |
Tumor cell/immune cell multivalent receptor engager – bio-nanoparticle (timre-bnp)
|